Text
Industry
Sponsored by
This partnership emerges as a strategic move to capitalize on the expanding global microbiome market.
Industry
Sponsored by
Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.
The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.
The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.
MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.
The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.
The findings of a recent study suggest that in bacterial vaginosis, certain vaginal microbes disrupt the protective glycans on vaginal epithelial cells, altering processes that mediate cell turnover, death and…
This strategic acquisition is set to reshape the landscape of microbiome research, extending its applications far beyond human health.
The study seeks to identify specific microbial and metabolic markers in the small intestinal fluid and blood of PD patients, offering new avenues for therapeutic intervention.
The findings of a recent study suggest that different factors, including maternal seeding and phage persistence in the gut, contribute to the colonization of the gut by phages.
